• Oruka Therapeutics Chief Medical Officer Joana Goncalves sold 7,000 common shares on October 15, 2026.
• Sales carried weighted-average prices ranging from $73.8894 to $77.71 per share.
• She exercised employee stock options for 3,500 shares at $6.84 and employee warrants for 3,500 shares at $7.8.
• Her direct common stock holdings totaled 31,771 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000108), on October 15, 2026, and is solely responsible for the information contained therein.